Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lazolex Gel for Herpes Simplex Infections
NCT06089252Phase 2Completed
- Sponsor
- Iveriapharma
- Start
- Nov 2007
- Primary completion
- Dec 2007
- Modality
- Hydrogel Systems, Small Molecules
01
Overview
A Phase 2 trial of Lazolex in herpes simplex virus infection, sponsored by Iveriapharma. Started Nov 2007; status: completed.
02
Drugs
Lazolex
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT06089252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06089252.